616 related articles for article (PubMed ID: 18638220)
1. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
Desai N; Allen J; Ali I; Venning V; Wojnarowska F
Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.
Sakuma-Oyama Y; Powell AM; Oyama N; Albert S; Bhogal BS; Black MM
Br J Dermatol; 2004 Jul; 151(1):126-31. PubMed ID: 15270881
[TBL] [Abstract][Full Text] [Related]
4. Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects.
Wieland CN; Comfere NI; Gibson LE; Weaver AL; Krause PK; Murray JA
Arch Dermatol; 2010 Jan; 146(1):21-5. PubMed ID: 20083688
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
[TBL] [Abstract][Full Text] [Related]
7. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
8. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
Iwata Y; Komura K; Kodera M; Usuda T; Yokoyama Y; Hara T; Muroi E; Ogawa F; Takenaka M; Sato S
Arch Dermatol; 2008 Jan; 144(1):41-8. PubMed ID: 18209167
[TBL] [Abstract][Full Text] [Related]
9. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
10. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
[TBL] [Abstract][Full Text] [Related]
11. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.
Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA
J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259
[TBL] [Abstract][Full Text] [Related]
12. Absence of anti-BP180 antibodies in mothers of infants with bullous pemphigoid.
Chiavérini C; Hamel-Teillac D; Gilbert D; Prost Y
Br J Dermatol; 2006 May; 154(5):839-43. PubMed ID: 16634883
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid: a retrospective study of 138 patients.
Charneux J; Lorin J; Vitry F; Antonicelli F; Reguiai Z; Barbe C; Tabary T; Grange F; Bernard P
Arch Dermatol; 2011 Mar; 147(3):286-91. PubMed ID: 21422334
[TBL] [Abstract][Full Text] [Related]
14. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
16. Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.
Mariotti F; Grosso F; Terracina M; Ruffelli M; Cordiali-Fei P; Sera F; Zambruno G; Mastrogiacomo A; Di Zenzo G
Br J Dermatol; 2004 Nov; 151(5):1004-10. PubMed ID: 15541078
[TBL] [Abstract][Full Text] [Related]
17. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
[TBL] [Abstract][Full Text] [Related]
18. Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile.
Schachter M; Brieva JC; Jones JC; Zillikens D; Skrobek C; Chan LS
J Am Acad Dermatol; 2001 Nov; 45(5):747-54. PubMed ID: 11606928
[TBL] [Abstract][Full Text] [Related]
19. Brunsting-Perry type localized bullous pemphigoid, possibly induced by furosemide administration and sun exposure.
TAKEICHI S; KUBO Y; ARASE S; HASHIMOTO T; ANSAI S
Eur J Dermatol; 2009; 19(5):500-3. PubMed ID: 19502152
[TBL] [Abstract][Full Text] [Related]
20. Bullous pemphigoid: serum antibody titre and antigen specificity.
Pas HH; de Jong MC; Jonkman MF; Heeres K; Slijper-Pal IJ; van der Meer JB
Exp Dermatol; 1995 Dec; 4(6):372-6. PubMed ID: 8608345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]